Cover Image
市場調查報告書

黃斑部病變:全球臨床實驗檢討

Macular Degeneration Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 232273
出版日期 內容資訊 英文 115 Pages
訂單完成後即時交付
價格
Back to Top
黃斑部病變:全球臨床實驗檢討 Macular Degeneration Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月11日 內容資訊: 英文 115 Pages
簡介

本報告提供全球黃斑部病變的臨床實驗的相關調查,各地區臨床實驗數資料,實驗階段,實驗情形,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 黃斑部病變
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • 對臨床實驗有所貢獻的前五國 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 對臨床實驗有所貢獻的前五國 - 中南美
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 黃斑部病變
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 黃斑部病變 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • Novartis AG
  • 臨床實驗概要; Novartis AG
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • GlaxoSmithKline plc
  • 臨床實驗概要; GlaxoSmithKline plc
  • Notal Vision Ltd.
  • 臨床實驗概要; Notal Vision Ltd.
  • Eyetech Pharmaceuticals, Inc.
  • 臨床實驗概要; Eyetech Pharmaceuticals, Inc.
  • Allergan, Inc.
  • 臨床實驗概要; Allergan, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • 臨床實驗概要; Regeneron Pharmaceuticals, Inc.
  • F. H;fmann-La Roche Ltd.
  • 臨床實驗概要; F. H;fmann-La Roche Ltd.
  • OPKO Health, Inc.
  • 臨床實驗概要; OPKO Health, Inc.
  • Ophthotech Corp.
  • 臨床實驗概要; Ophthotech Corp.
  • Alcon Research Ltd.
  • 臨床實驗概要; Alcon Research Ltd.
  • Genaera Liquidating Trust
  • 臨床實驗概要; Genaera Liquidating Trust
  • NeoVista, Inc.
  • 臨床實驗概要; NeoVista, Inc.
  • Genentech, Inc.
  • 臨床實驗概要; Genentech, Inc.
  • Advanced Cell Technology, Inc.
  • 臨床實驗概要; Advanced Cell Technology, Inc.
  • Bayer AG
  • 臨床實驗概要; Bayer AG
  • Lpath, Inc.
  • 臨床實驗概要; Lpath, Inc.
  • Oraya Therapeutics, Inc.
  • 臨床實驗概要; Oraya Therapeutics, Inc.
  • Acucela Inc.
  • 臨床實驗概要; Acucela Inc.
  • Othera Pharmaceuticals, Inc.
  • 臨床實驗概要; Othera Pharmaceuticals, Inc.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Medical University of Vienna
  • 臨床實驗概要; Medical University of Vienna
  • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser 手術
  • 臨床實驗概要; The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser 手術
  • Vitreous-Retina-Macula Consultants of New York
  • 臨床實驗概要; Vitreous-Retina-Macula Consultants of New York
  • 京都大學
  • 臨床實驗概要; 京都大學
  • Johns Hopkins University
  • 臨床實驗概要; Johns Hopkins University
  • Lawson Health Research Institute
  • 臨床實驗概要; Lawson Health Research Institute
  • Retina Research Foundation
  • 臨床實驗概要; Retina Research Foundation
  • Asociacion para Evitar la Ceguera en Mexico I.A.P.
  • 臨床實驗概要; Asociacion para Evitar la Ceguera en Mexico I.A.P.
  • Manhattan Eye Ear & Throat Hospital
  • 臨床實驗概要; Manhattan Eye Ear & Throat Hospital
  • University of California, Davis
  • 臨床實驗概要; University of California, Davis
  • University of California, San Diego
  • 臨床實驗概要; University of California, San Diego
  • Maastricht University Medical Center
  • 臨床實驗概要; Maastricht University Medical Center
  • University of Pittsburgh
  • 臨床實驗概要; University of Pittsburgh
  • University Health Network
  • 臨床實驗概要; University Health Network
  • Assistance Publique - Hopitaux de Paris
  • 臨床實驗概要; Assistance Publique - Hopitaux de Paris
  • University Hospital Inselspital, Berne
  • 臨床實驗概要; University Hospital Inselspital, Berne
  • University of Sao Paulo
  • 臨床實驗概要; University of Sao Paulo
  • Kyungpook National University
  • 臨床實驗概要; Kyungpook National University
  • 聖隸濱松醫院
  • 臨床實驗概要; 聖隸濱松醫院
  • Rudolf Foundation Clinic
  • 臨床實驗概要; Rudolf Foundation Clinic
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 黃斑部病變 全球治療藥物市場, 臨床實驗 各地區
  • 黃斑部病變 全球治療藥物市場, 臨床實驗 , 各國排名
  • 黃斑部病變 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
  • 黃斑部病變 治療藥物的臨床實驗, 亞太地區, 前五國
  • 黃斑部病變 治療藥物的臨床實驗, 歐洲, 前五國
  • 黃斑部病變 治療藥物的臨床實驗, 北美, 前幾名國家
  • 黃斑部病變 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 黃斑部病變 治療藥物的臨床實驗, 中南美, 前五國
  • 黃斑部病變 治療藥物的臨床實驗, 金磚四國 各國
  • 黃斑部病變 治療藥物的臨床實驗, G7 各國
  • 黃斑部病變 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 黃斑部病變 治療藥物的臨床實驗, E7 各國
  • 黃斑部病變 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 黃斑部病變 全球治療藥物市場, 臨床實驗 各階段
  • 黃斑部病變 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 黃斑部病變 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
  • 黃斑部病變 全球治療藥物市場, 暫時停止的臨床實驗
  • 黃斑部病變 全球治療藥物市場, 中止的臨床實驗
  • 黃斑部病變 全球治療藥物市場, 終止的臨床實驗
  • 黃斑部病變 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 黃斑部病變 全球治療藥物臨床實驗, 主要的贊助商
  • 黃斑部病變 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 黃斑部病變 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Novartis AG
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Pfizer Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - GlaxoSmithKline plc
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Notal Vision Ltd.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Eyetech Pharmaceuticals, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Allergan, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Regeneron Pharmaceuticals, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - F. H;fmann-La Roche Ltd.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - OPKO Health, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Ophthotech Corp.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Alcon Research Ltd.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Genaera Liquidating Trust
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - NeoVista, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Genentech, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Advanced Cell Technology, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Bayer AG
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Lpath, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Oraya Therapeutics, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Acucela Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Othera Pharmaceuticals, Inc.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Medical University of Vienna
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser 手術
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Vitreous-Retina-Macula Consultants of New York
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - 京都大學
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Johns Hopkins University
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Lawson Health Research Institute
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Retina Research Foundation
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Asociacion para Evitar la Ceguera en Mexico I.A.P.
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Manhattan Eye Ear & Throat Hospital
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - University of California, Davis
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - University of California, San Diego
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Maastricht University Medical Center
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - University of Pittsburgh
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - University Health Network
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Assistance Publique - Hopitaux de Paris
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - University Hospital Inselspital, Berne
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - University of Sao Paulo
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Kyungpook National University
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - 聖隸濱松醫院
  • 黃斑部病變 全球治療藥物臨床實驗市場, 臨床實驗 - Rudolf Foundation Clinic

圖表一覽

圖表一覽

  • 黃斑部病變 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 黃斑部病變 全球治療藥物市場, 臨床實驗 , 各國排名
  • 黃斑部病變 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
  • 黃斑部病變 治療藥物的臨床實驗, 亞太地區, 前五國 (%)
  • 黃斑部病變 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 黃斑部病變 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
  • 黃斑部病變 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
  • 黃斑部病變 治療藥物的臨床實驗, 中南美, 前五國 (%)
  • 黃斑部病變 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 黃斑部病變 治療藥物的臨床實驗, G7 各國 (%)
  • 黃斑部病變 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 黃斑部病變 治療藥物的臨床實驗, E7 各國 (%)
  • 黃斑部病變 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 黃斑部病變 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 黃斑部病變 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 黃斑部病變 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
  • 黃斑部病變 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 黃斑部病變 全球治療藥物臨床實驗, 主要的贊助商
  • 黃斑部病變 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 黃斑部病變 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2714CTIDB

GlobalData's clinical trial report, "Macular Degeneration Global Clinical Trials Review, H1, 2015" provides an overview of Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Macular Degeneration
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Macular Degeneration
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Macular Degeneration Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Macular Degeneration
      • Apr 30, 2015: Ocata Therapeutics Announces Positive Results in Treating Macular Degeneration Using Fully Differentiated Stem Cell-Derived Retinal Pigment Epithelium Cells in Asian Patients
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Regeneron Pharmaceuticals, Inc.
      • Clinical Trial Overview of Regeneron Pharmaceuticals, Inc.
      • Ophthotech Corp.
      • Clinical Trial Overview of Ophthotech Corp.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • QLT Inc.
      • Clinical Trial Overview of QLT Inc.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Eyetech Pharmaceuticals, Inc.
      • Clinical Trial Overview of Eyetech Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • King's College Hospital NHS Foundation Trust
      • Clinical Trial Overview of King's College Hospital NHS Foundation Trust
      • Manhattan Eye Ear & Throat Hospital
      • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
      • Vitreous-Retina-Macula Consultants of New York
      • Clinical Trial Overview of Vitreous-Retina-Macula Consultants of New York
      • Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      • Clinical Trial Overview of Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi
      • Kagawa University
      • Clinical Trial Overview of Kagawa University
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • Nagoya City University
      • Clinical Trial Overview of Nagoya City University
      • The Johns Hopkins University
      • Clinical Trial Overview of The Johns Hopkins University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Macular Degeneration Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Macular Degeneration Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Macular Degeneration Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthotech Corp., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College Hospital NHS Foundation Trust, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Vitreous-Retina-Macula Consultants of New York, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagawa University, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University, 2015*
  • Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015*

List of Figures

  • Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top